Tirzepatide TR20 is a synthetic modified peptide research compound used to study the metabolic mechanism, receptor function, and peptide pharmacology of the GLP-1 and GIP dual receptor-related signaling pathways.
Tirzepatide TR20 is a synthetic modified peptide compound consisting of 39 amino acids, belonging to the GLP-1/GIP dual receptor agonist class. This molecule, through structural optimization and fatty acid modification, is designed to investigate incretin-related receptor signaling pathways, the relationship between molecular structure and function, and multi-target metabolic regulatory mechanisms. The product is supplied as a white to off-white lyophilized powder, and its quality is evaluated by HPLC purity analysis and LC-MS identification.
Tirzepatide TR20 is primarily used in metabolic biology, receptor signaling studies, and peptide pharmacology, including research on the activation mechanisms of GLP-1 and GIP receptors, cell signal transduction analysis, glucose metabolism, energy balance mechanisms, receptor binding experiments, and the optimization of novel peptide drug structures. This compound can serve as a research tool to explore the synergistic effects of dual receptors and related metabolic signaling networks.
Freeze-dried powder state:
Recommended:
Long-term storage:
-20℃
Requirements:
✅ Protect from light
✅ Dry
✅ Store in an airtight container
Avoid:
High temperatures
Repeated freeze-thaw cycles
Prolonged exposure to air
Retatrutide (RT10) is a synthetic peptide research compound designed as a triple...
Retatrutide (RT20) is a novel synthetic modified peptide, with the research code...
Retatrutide RT30 is a 30mg research-grade peptide product of Retatrutide (LY3437...
Contact our team for volume discounts and custom peptide services